Kombinirano liječenje senilne neovaskularne makularne degeneracije primjenom bevacizumaba i fotodinamske terapije : doktorski rad
Introduction: Age-Related Macular Degeneration is a leading cause of severe visual loss in
population over 50 in Western countries with neovascular subtype accounting for the most of
severe cases. Available treatment modalities including Vascular Endothelial Growth Factor
inhibitors (antiVEGF) and verteporfin photodynamic therapy (PDT) are of limited efficiency
and require prolonged treatment.…
Kaasautorid
- Gabrić, Nikica
Looja
- Lazić, Ratimir
Kirjastus
- University of Rijeka. Faculty of Medicine.
Teema
- BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.
- Surgery. Orthopaedics. Ophthalmology
- AMD
- bevacizumab
- PDT
- verteporfin
- antiVEGF
Üksuse liik
- info:eu-repo/semantics/doctoralThesis
- text
Kuupäev
- 2010-12-23
- 2010-12-23
Kaasautorid
- Gabrić, Nikica
Looja
- Lazić, Ratimir
Kirjastus
- University of Rijeka. Faculty of Medicine.
Teema
- BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.
- Surgery. Orthopaedics. Ophthalmology
- AMD
- bevacizumab
- PDT
- verteporfin
- antiVEGF
Üksuse liik
- info:eu-repo/semantics/doctoralThesis
- text
Kuupäev
- 2010-12-23
- 2010-12-23
Pakkuja institutsioon
Agregaator
Selles üksuses sisalduva meedia õiguste avaldus (kui pole teisiti märgitud)
- http://rightsstatements.org/vocab/InC/1.0/
Identifikaator
- https://dr.nsk.hr/islandora/object/svkri:3122
- https://urn.nsk.hr/urn:nbn:hr:188:892351
- https://www.unirepository.svkri.uniri.hr/islandora/object/svkri:3122
- https://dr.nsk.hr/islandora/object/svkri%3A3122/datastream/TN/view/
Formaat
- application/pdf
Keel
- hrv
Pakkuja riik
- Croatia
Kollektsiooni nimi
Esimest korda avaldati Europeana
- 2019-04-05T13:44:36.130Z
Viimati andmeid pakkuvast institutsioonist uuendatud
- 2019-04-05T13:44:36.130Z